Coming Soon, Cure to Drug-resistant Tuberculosis!

Tuberculosis is a form of the disease that cannot be cured with traditional therapies. A group of scientists have discovered potential treatment for the drug-resistant TB.

A team of scientists have discovered a potential treatment for drug-resistant tuberculosis, a form of the disease that cannot be cured with conventional therapies.

While standard anti-TB drugs can cure most people of Mycobacterium tuberculosis infection, improper use of antibiotics has led to new strains of the bacterium resistant to the two most powerful medications, isoniazid and rifampicin.

Industrialization, World War I, Soviet Collapse Helped Spread of Drug-resistant Tuberculosis
Some of the drug-resistant tuberculosis (TB) bacteria have spread from East Asia in waves propelled by industrialization, World War I and Soviet collapse.

Lead author Vasu Nair from the University of Georgia said that multi-drug resistant TB is spreading rapidly in many parts of the world and there is a tremendous need for new therapies, and they think their laboratory has developed a strong candidate that disrupts fundamental steps in the bacterium's reproduction process.

The compound, which works by binding to magnesium and specific amino acids found within the bacterium, interrupting the production of RNA, strongly inhibits the growth of the bacterium and renders it incapable of reproducing and spreading infection and shows very low levels of cytotoxicity, which means that it is not harmful to the body, said Nair.

Nair added that all their tests were very favorable. The half-life is a little over 14 hours and all traces of the drug are expected to be cleared through normal bodily functions.

A Resumed Effort to Eradicate Tuberculosis by Brihanmumbai Municipal Corporation With Amitabh Bachchan
Bachchan is the face of Brihanmumbai Municipal Corporation's (BMC) new TB campaign that will look at fighting back drug-sensitive cases.

Researchers also discovered through preliminary experiments that it also exhibited strong anti-HIV properties, opening the door for dual therapeutic applications.

Nair concluded that this discovery of dual activity against both retroviruses and drug-resistant gram-positive bacteria is unique and opens a new chapter in drug discovery in this area.

Tuberculosis-Diabetes Co-Epidemic Looms, Experts Warn
A new report warns of tuberculosis-diabetes epidemic as the two diseases intertwine in many countries, driven in part by a rise in unhealthy lifestyles.

The study appears in Bioorganic and Medicinal Chemistry Letters.

Big Strides Made in Fighting Tuberculosis: WHO
The known tally of people with tuberculosis rose last year but overall major progress is being made in rolling back the disease, reveal the World Health Organization.